Verastem, Inc., (NASDAQ: VSTM) a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that members of the management team will be presenting at several upcoming conferences. The presentation details are as follows:
• Molecular Medicine Tri-Conference symposium on Targeting Cancer Stem Cells on February 12, 2013, at 8:30am PT at the Moscone North Conference Center in San Francisco, CA
